Ibex Medical Raises $11M For AI-Based Pathology Tools
Israeli firm Ibex Medical Analytics has secured $11M in Series A funding, led by aMoon, to expand development of its artificial intelligence applications for cancer diagnostics.
You may also be interested in...
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.